Text this: Polyethylene glycol loxenatide modulates lipid metabolism and insulin resistance through lncRNA steroid receptor RNA activator/cellular nucleic acid binding protein/Rho‐associated coiled‐coil kinase 2 axis in type 2 diabetes mellitus.